期刊文献+

卡托普利与洛伐他汀联用对阿霉素肾病大鼠血清IL-6的影响 被引量:3

Effects of combination of captopril with lovastatin on serum IL-6 in rats with Adriamycin-induced nephropathy
下载PDF
导出
摘要 目的探讨卡托普利与洛伐他汀联用对阿霉素肾病大鼠血清白介素-6(IL-6)的影响,以及两药联用保护肾脏的可能机制。方法雄性SD大鼠150只,适应性喂养2周后,随机抽取18只为正常对照组(A组),另外132只制作阿霉素肾病模型。2周末,造模成功的120只随机分为4组:B组为模型对照组(n=30);C组为卡托普利治疗组(n=30);D组为洛伐他汀治疗组(n=30);E组为两药联用组(n=30)。分别于2、4、6周末,遵循随机化原则,按n=6,分层抽取各组样本,收集实验前24 h尿液及实验时的腹动脉血,所取样本置入-20℃冰箱中保存待测。结果卡托普利与洛伐他汀联用,可进一步降低血清白介素-6及胆固醇、甘油三酯浓度,减少尿蛋白,提高血浆白蛋白浓度,其疗效优于C组、D组。结论卡托普利与洛伐他汀联用可更有效地保护阿霉素大鼠肾脏功能。 Objective To investigate the effects of combination of captopril with lovastatin on serum IL-6 and its likely protective mechanism.Methods 150 male Sprague-Dawlay rats were chose.After being fed 2 weeks adaptively,18 rats were divided into normal group(A,n=18) randomly,the rest 132 for making model group.At the end of 2nd week,120 adriamycin-induced nephropathy rats were divided into four groups randomly:B for exprimental control group(n=30),C for captopril treated group(n=30),D for lovstatin treated group(n=30),and E for combination of captopril with lovastatin treated group(n=30).The rats were killed at the end of 2nd,4th,6th weekend,and the samples were stratified randomly(n=6).The collected urine and abdominal aorta blood were reserved in refrigerator at-20 ℃ to be detected.Results Combination of captopril with lovastatin was more effective on inhibiting secretion of IL-6 of adriamycin-induced nephropathy rats,lowing IL-6,CHOL,TG and elevating albumin in serum than captopril or lovastatin.Conclusion Combination of captopril with lovastatin is more effective on protecting the kidney of adriamycin-induced nephropathy rats.
出处 《实用药物与临床》 CAS 2008年第2期65-67,共3页 Practical Pharmacy and Clinical Remedies
关键词 阿霉素肾病 白介素-6 卡托普利 洛伐他汀 Adriamycin-induced nephropathy IL-6 Captopril Lovastatin
  • 相关文献

参考文献7

  • 1Kielar ML, John R, Bennett M, et al. Maladaptive role of IL-6 in isehemie acute renal failure[J]. J Am Soc Nephrol, 2005, 16 (11) : 3315-3325.
  • 2程叙扬,李晓玫,唐嘉薇,王海燕.微小病变患者尿蛋白对肾小管上皮细胞的损伤作用及其机制研究[J].中华肾脏病杂志,2002,18(6):398-402. 被引量:21
  • 3Marja-Liisa Solin, Heikki Ahola, Anni Haltia, et al. Lipid peroxidation in httrnan proteinurie disease[J]. Kidney Int, 2001, 59 (2) :481-487.
  • 4Kim SI, Han DC, Lee HB. Lovastatin inhibits transforming growth faetor-β expression in diabetic rat glomeruli and cultured rat mesangial cells[J] .J Am Soc Nephrol, 2000,11(1) :80-87.
  • 5Zoja C, Coma D, Rotfoli D, et al. Effect of combining ACE inhibitor and statin in severe experimental rats[J]. Kidney Int, 2002, 61(5) : 1635-1645.
  • 6Suzuki Y, Ruzi-Ortega M, Lorenzo D, et al. Inflammation and angiotensin Ⅱ [J]. International Journal of Biochemistry & Cell Biology, 2003, 35(6) .881-900.
  • 7李学旺,吕向化,宋红梅,黄利伟.苯那普利对阿霉素肾病大鼠系膜基质的影响[J].中华肾脏病杂志,2000,16(1):44-46. 被引量:27

二级参考文献17

  • 1Burton C, Harris KPG. The role of proteinuria in the progress of chronic renal failure. Am J Kidney Dis, 1996,27: 765-775.
  • 2Schreiner GF. Renal toxicity of albumin and other lipoproteins.Curr Opin Nephrol Hyperten, 1995,4: 369-373.
  • 3Doon S. Bulk purification by fractional precipitation. In: Doonan S, ed. Methods in molecular biology: Protein purification protocols.Ottawa: Human Press Inc, 1996. 135-144.
  • 4Thomas ME, Brunskill NJ, Harris KPG, et al. Proteinuria induces tubular turnover: A potential mechanism for tubular atrophy.Kidney Int, 1999,55: 890-898.
  • 5Peruzzi L, Trusolino L, Amore A, et al. Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates αvβ5 integrin. Kidney 1nt,1996,50: 1310-1320.
  • 6Chen L, Wang Y, Tay YC, et al. Priteinuria and tubulointerstitial injury. Kidney Int,1997,52 Suppl 61: S60-S62.
  • 7Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int, 1995, 47: 1546-1557.
  • 8Ng YY, Huang TP, Yang WC, et al. Evidence for tubular epithelialmyofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephroctomized rats. Kidney Int, 1998, 54:864-876.
  • 9Strutz F, Muller G, Neilson EG. Transdifferentiation: A new angle on renal fibrosis. Exp Nephrol, 1996,4: 267-270.
  • 10Maschio G,Alberti D,Janin G,et al.Effect of the angiotensinconverting-enzyme inhibitor Benazepril on the progression of chronicrenal insufficiency[].New England Journal of Homeopathy.1996

共引文献46

同被引文献48

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部